Xiangjie Sun
Xiangjie Sun
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Jessica A Belser
Jessica A Belser
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Claudia Pappas
Claudia Pappas
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Joanna A Pulit-Penaloza
Joanna A Pulit-Penaloza
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Nicole Brock
Nicole Brock
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Hui Zeng
Hui Zeng
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Hannah M Creager
Hannah M Creager
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Shoshona Le
Shoshona Le
cBattelle Memorial Institute, Atlanta, Georgia, USA
c,
Malania Wilson
Malania Wilson
cBattelle Memorial Institute, Atlanta, Georgia, USA
c,
Amanda Lewis
Amanda Lewis
bInfectious Diseases Pathology Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
b,
Thomas J Stark
Thomas J Stark
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Wun-Ju Shieh
Wun-Ju Shieh
bInfectious Diseases Pathology Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
b,
John Barnes
John Barnes
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Terrence M Tumpey
Terrence M Tumpey
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a,
Taronna R Maines
Taronna R Maines
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
a
aInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
bInfectious Diseases Pathology Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
cBattelle Memorial Institute, Atlanta, Georgia, USA
Citation Sun X, Belser JA, Pappas C, Pulit-Penaloza JA, Brock N, Zeng H, Creager HM, Le S, Wilson M, Lewis A, Stark TJ, Shieh W-J, Barnes J, Tumpey TM, Maines TR. 2019. Correction for Sun et al., “Risk assessment of fifth-wave H7N9 influenza A viruses in mammalian models.” J Virol 93:e00476-19. https://doi.org/10.1128/JVI.00476-19.
Collection date 2019 Jul 1.
PDF (237.0 KB)
